Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Earle

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Surgical Oncology|June 26, 2010
Meeting the 12 lymph node (LN) benchmark in colon cancerA Rajput, D Romanus, M R Weiser, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 2, 2023
Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall SurvivalW F Dai, S Habbous, R Saluja, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuationT P Hanna, T Baetz, J Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 8, 2007
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt, K Stuart, C S Fuchs, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2021
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian ProvincesJ M Beca, W F Dai, R E Pataky, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
The generation of two specific cancer costing algorithms using Ontario administrative databasesN Mittmann, S Y Cheng, N Liu, et al.
Current Oncology (Toronto, Ont.)|November 3, 2016
Predictors of adjuvant treatment for pancreatic adenocarcinoma at the population levelD J Kagedan, M E Dixon, R S Raju, et al.
Current Oncology (Toronto, Ont.)|January 10, 2013
Population-based home care services in breast cancer: utilization and costsN Mittmann, P K Isogai, R Saskin, et al.
Current Oncology (Toronto, Ont.)|December 10, 2014
Health system costs for stage-specific breast cancer: a population-based approachN Mittmann, J M Porter, J Rangrej, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Surgical Oncology|June 26, 2010
Meeting the 12 lymph node (LN) benchmark in colon cancerA Rajput, D Romanus, M R Weiser, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 2, 2023
Comparative Effectiveness of FOLFIRINOX Versus Gemcitabine and Nab-paclitaxel in Initially Unresectable Locally Advanced Pancreatic Cancer: A Population-based Study to Assess Subsequent Surgical Resection and Overall SurvivalW F Dai, S Habbous, R Saluja, et al.
Current Oncology (Toronto, Ont.)|December 23, 2017
Mental health services use by melanoma patients receiving adjuvant interferon: association of pre-treatment mental health care with early discontinuationT P Hanna, T Baetz, J Xu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 8, 2007
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt, K Stuart, C S Fuchs, et al.
Journal of Surgical Oncology|August 22, 2009
Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancerC C Earle, M R Weiser, A Ter Veer, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 30, 2021
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian ProvincesJ M Beca, W F Dai, R E Pataky, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
The generation of two specific cancer costing algorithms using Ontario administrative databasesN Mittmann, S Y Cheng, N Liu, et al.
Current Oncology (Toronto, Ont.)|November 3, 2016
Predictors of adjuvant treatment for pancreatic adenocarcinoma at the population levelD J Kagedan, M E Dixon, R S Raju, et al.
Current Oncology (Toronto, Ont.)|January 10, 2013
Population-based home care services in breast cancer: utilization and costsN Mittmann, P K Isogai, R Saskin, et al.
Current Oncology (Toronto, Ont.)|December 10, 2014
Health system costs for stage-specific breast cancer: a population-based approachN Mittmann, J M Porter, J Rangrej, et al.
Pageof 5